Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Anacor Pharmaceuticals Inc    ANAC

Delayed Quote. Delayed  - 06/23 09:59:59 pm
99.2 USD   +0.03%
08:57a PFIZER : completes acquisition of Anacor
05/31 GLAXOSMITHKLINE : How Wellcome, Gates profit from medical tech
05/31DJJazz Pharmaceuticals Agrees to Buy Celator for About $1.5 Billion
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/21/2016 06/22/2016 06/23/2016 06/24/2016 06/23/2016 Date
99.2(c) 99.17(c) 99.2(c) 0(c) 99.2 Last
2 952 985 2 432 818 5 373 306 300 5 373 306 Volume
-0.06% -0.03% +0.03% -100.00% +0.03% Change
More quotes
Financials ($)
Sales 2016 80,8 M
EBIT 2016 -65,4 M
Net income 2016 -69,5 M
Debt 2016 -
Yield 2016 -
Sales 2017 255 M
EBIT 2017 -4,63 M
Net income 2017 1,44 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017 0,00
Capi. / Sales2016 -
Capi. / Sales2017 -
Capitalization -
More Financials
Company
Anacor Pharmaceuticals, Inc. operates as a biopharmaceutical company, which focuses on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform.The company has discovered following compounds that are currently in development including... 
More about the company
Surperformance© ratings of Anacor Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ANACOR PHARMACEUTICALS INC
08:57a PFIZER : completes acquisition of Anacor
06/24 ANACOR PHARMACEUTICALS, INC. : Completion of Acquisition or Disposition of Asset..
06/08 ANACOR PHARMACEUTICALS, INC. : Amendments to Articles of Inc. or Bylaws; Change ..
05/31 GLAXOSMITHKLINE PHARMACEUTICALS : How Wellcome, Gates profit from medical tech
05/31DJJazz Pharmaceuticals Agrees to Buy Celator for About $1.5 Billion
05/31DJJazz Pharmaceuticals Nears Deal to Buy Celator for About $1.5 Billion
05/26 Anacor received rival bid before Pfizer deal - filing
05/23 ACQUISITION OF ANACOR PHARMACEUTICAL : ANAC) Under Investigation for Investors
05/21 Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Ana..
05/20 Levi & Korsinsky, LLP Announces Investigation Into Whether the Sale of Anacor..
More news
Sector news : Biotechnology & Medical Research - NEC
06/25 NOVARTIS : SC requests solicitor general to consider on biosimilars
06/24DJMedpace Files for IPO
06/24DJMEDIVATION : Glass Lewis Backs Medivation Board in Sanofi Dispute
06/24 MEDIVATION : Glass Lewis Recommends Medivation's Stockholders Support the Compan..
06/24 MEDIVATION : Glass Lewis Recommends Medivation’s Stockholders Support the ..
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
06/24 Brexit Insurance - 3 Ways To Protect Your Portfolio Today
06/14 Ziarco Lacks Sparkle In Atopic Dermatitis
06/13 Can Pfizer's Outperformance Continue?
06/07 Singular's Proprietary Major Market Indicators Index Sends A Neutral Signal A..
06/06 Anacor Postmortem
Advertisement
Chart ANACOR PHARMACEUTICALS INC
Duration : Period :
Anacor Pharmaceuticals Inc Technical Analysis Chart | ANAC | US0324201013 | 4-Traders
Full-screen chart
Technical analysis trends ANACOR PHARMACEUT...
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions